Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT ID: NCT00002226
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SU5416
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are at least 18 years old.
* Are HIV-positive.
* Have KS with at least 5 skin lesions.
* Have been in stable condition for at least 6 weeks prior to study entry, if receiving antiretroviral therapy.
* Agree to use effective methods of birth control during the study.
Exclusion Criteria
* Have had surgery within 4 weeks of study entry.
* Have taken certain medications, including therapy for KS, within 3 weeks prior to study entry.
* Have pulmonary KS (KS in your lungs).
* Have certain serious medical conditions, including liver or kidney problems, certain infections, and certain cancers.
* Are allergic to Cremophor.
* Have not recovered from previous cancer treatment (chemotherapy, radiotherapy, or immunotherapy).
* Are pregnant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SUGEN
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norris Cancer Ctr / USC
Los Angeles, California, United States
UCLA Care Ctr / Ctr for Hlth Sciences
Los Angeles, California, United States
Saint Francis Mem Hosp / HIV Care Unit
San Francisco, California, United States
New York Univ Med Ctr
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gill P, Arasteh K, Jacobs M, Friedman-Kiel A, Miles S, Gracey S, Hannah A, Langecker P. A multicenter, dose-escalating study in patients with AIDS-related Kaposi's Sarcoma 39th Intersci Conf Antimicrob Agents Chemother. 1999 Sept 26-29
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5416.003
Identifier Type: -
Identifier Source: secondary_id
294A
Identifier Type: -
Identifier Source: org_study_id